Our Story · Guelph, Ontario · Founded 2008
A deep science
platform.
Zentek holds a graphite deposit that has demonstrated ultra-high purity in bench scale purification testwork, a growing patent portfolio, and three structurally distinct commercial platforms. New leadership is executing a unified strategy across all three.
deep science platform
\ dēp ˈsī-əns ˈplat-ˌfȯrm \
Industry has a problem; Zentek delivers development-on-demand solutions and secures the IP. One governing model — client-funded research and development, with Zentek retaining commercial ownership of innovations that result.
What we are
One deep science foundation.
Three distinct platforms.
Zentek operates three distinct businesses — Albany Graphite, our graphene platform, and Triera Biosciences. Government grants have the potential to offset a meaningful portion of R&D costs. A patent portfolio that compounds with every engagement.
Zentek is working to advance the three platforms simultaneously — at the convergence of critical minerals supply chain urgency, advanced material performance demand, and next-generation therapeutic development. And in areas of great need, government grants have the potential to offset a meaningful portion of R&D costs. A patent portfolio that has the potential to grow with every engagement.
Client-funded R&D
Industry funds the research program. Zentek develops the solution. Potential development fees generate potential near-term revenue with the goal of generating future royalty streams.
IP ownership
Zentek will seek to retain commercial rights to innovations developed through client engagements, including government funded projects.
Asset-light, high margin
Our focus will be to ensure partners handle production scale-up. Potential premium margins on specialized expertise — the same structure that defines the most valuable specialty chemicals and biotech companies.
Non-dilutive by design
Federal and provincial funding programs have the potential to offset a meaningful portion of R&D costs through non-dilutive funding opportunities.
Three markets, one thesis
Critical minerals supply chain urgency, advanced material performance demand, and next-generation therapeutic development — addressed through one repeatable commercial engine.
Validated deep science
A deposit with 5N purity demonstrated at bench scale, 25+ patent families, and a research base built with McMaster University.
The repositioning
An extraordinary set of opportunities.
A new unified strategy to connect them.
Since December 2025, Zentek has repositioned from a collection of individual projects into a more unified platform company — five strategic shifts, one governing model.
01 · Lead asset defined
The foundational asset.
The Albany graphite deposit is established as our foundational critical mineral asset — 5N purity, low boron, no halogen contamination based on bench-scale testing. Potential to serve mission-critical markets where non-aligned supply is legally or strategically excluded.
Explore Albany
02 · Processing strategy
A materials provider, not a mine.
A potential advanced fluidized bed reactor (“FBR”) processing centre positioned as a materials provider, not a mine — a potential value-added supplier to nuclear, defense, and aerospace applications.
Read The Graphite Divide
03 · Coatings reframed
Development-on-demand graphene.
From a product company to a development-on-demand graphene-based solutions provider: industry has a problem, we deliver solutions and seek to secure the IP.
See the graphene platform
04 · Life sciences crystallised
An aptamer contract research organization.
Triera Biosciences is positioning itself for potential custom discovery, rapid diagnostics, and therapeutic development. The same client-funded, IP-ownership model applied to biotech.
Explore Triera
05 · One story
One deep science platform.
Zentek as a deep science platform company: validated assets, 25+ patent families, three distinct markets, one governing model.
Investor overviewIndustry has a problem, we deliver development-on-demand solutions and secure the IP.
Leadership team
The team executing the plan.
New leadership since December 2025 is executing a unified strategy across all three platforms.
Mohammed (Moe) Jiwan
Chief Executive Officer
Appointed December 1, 2025 with a mandate to reposition Zentek as a coherent deep science platform company, clarify the investment thesis, and execute across three platforms simultaneously. Background in technology and capital markets. Leading the Albany FBR commercialisation pathway, ZenGUARD™ US market development, Triera CRO launch, and capital structure initiatives.
Wendy Ford
Chief Financial Officer · Financial reporting and capital structure
Oversees financial reporting under IFRS, capital allocation across the three platforms, investor financial communications, and the current capital structure initiatives. Responsible for reconciliation of all financial figures prior to external disclosures, including the company's obligations as a foreign private issuer.
Ryan Shacklock, CPA, CA
SVP Strategy & Business Development
Leads investor relations, strategic communications, and partnership development across all three platforms. Primary point of contact for institutional investors, analysts, and strategic partners. Coordinates across Albany, our graphene platform, and Triera on commercial development activities.
Adam MacIntosh, Ph.D.
R&D Director · Research programs
Leads internal and external R&D activities across our graphene platform and biosciences platforms. Oversees research supply procurement, laboratory operations at the Guelph facility, and collaboration with the McMaster University research team. Primary technical contact for graphene platform CRO engagements and Triera diagnostic development programs.
Peter Wood, P.Eng., P.Geo.
VP Development · NI 43-101 Qualified Person
Designated Qualified Person under National Instrument 43-101 — responsible for technical oversight and sign-off of all technical content relating to the Albany Graphite deposit prior to external distribution. Oversees the updated PEA program, environmental baseline work, and Indigenous engagement.
Company credentials
A Well-established Base.
Guelph, Ontario
Graphene synthesis · coating application · laboratory testing · 25,000 sq ft.
~70 km NW of Hearst, Ontario
Porcupine Mining District · Our foundational critical mineral asset.
McMaster University
Exclusive 20-year aptamer license · 588 combined team publications · electrochemical sensor development · machine learning classification.